Mi Jin Oh
Overview
Explore the profile of Mi Jin Oh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
33
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oh M, Park J, Jeon J, Park M, Kang S, Kim S, et al.
Cancer
. 2025 Feb;
131(4):e35768.
PMID: 39955610
Background: Borrmann type-4 (B-4) advanced gastric cancer is challenging to diagnose through routine endoscopy, leading to a poor prognosis. The objective of this study was to develop an artificial intelligence...
2.
Lee S, Jeon J, Park J, Chang Y, Shin C, Oh M, et al.
Gastric Cancer
. 2024 Sep;
27(6):1351.
PMID: 39230777
No abstract available.
3.
Oh M, Kim S, Kim J, Na Y, Lee S, Lee J, et al.
PLoS One
. 2024 Jul;
19(7):e0306934.
PMID: 38980853
Background: Although several small cohort studies have shown the utility of argon plasma coagulation (APC) in the treatment of gastric dysplasia, its clinical significance has not been established. This study...
4.
Lee S, Jeon J, Park J, Chang Y, Shin C, Oh M, et al.
Gastric Cancer
. 2024 Jul;
27(5):1088-1099.
PMID: 38954175
Background: Accurate prediction of pathologic results for early gastric cancer (EGC) based on endoscopic findings is essential in deciding between endoscopic and surgical resection. This study aimed to develop an...
5.
Kim K, Kang N, Song S, Kim H, Kim Y, Oh M, et al.
Int J Radiat Oncol Biol Phys
. 2024 Apr;
120(2):432-438.
PMID: 38565405
Purpose: We aimed to investigate the safety and efficacy of HL301, a standardized combination product of 7 medicinal plants, in radiation pneumonitis in patients with unresectable non-small cell lung cancer...
6.
Lee S, Cho S, Chung H, Kim B, Oh M, Na Y, et al.
Gut Liver
. 2024 Mar;
18(6):992-1001.
PMID: 38509700
Background/aims: eradication can reduce the incidence of metachronous gastric neoplasm (MGN) after endoscopic submucosal dissection (ESD) for early gastric cancer (EGC). This study evaluated the risk of developing MGN after...
7.
Oh M, Han K, Kim B, Lim J, Kim B, Kim S, et al.
Medicine (Baltimore)
. 2023 Dec;
102(48):e36260.
PMID: 38050195
Obesity is a known risk factor for gastric cancer. However, the relationship between serum lipids and gastric cancer risk has not been fully established. We investigated the relationship between serum...
8.
Oh M, Shin D, Koh Y, Hong J, Kim I, Yoon S, et al.
In Vivo
. 2021 Jan;
35(1):617-622.
PMID: 33402517
Background/aim: For intermediate risk acute myeloid leukemia patients, allogeneic hematopoietic stem cell transplantation (alloSCT) and chemotherapy are equally recommended as consolidation after first complete remission (CR1). In real-world, alloSCT might...
9.
Oh M, Kim S, Park Y, Suh J, Yi S
Dement Neurocogn Disord
. 2019 Mar;
17(2):66-70.
PMID: 30906394
No abstract available.
10.
Oh M, Hwang H, Kim H, Lee G, Cho Y, Lee S, et al.
Clin Ther
. 2017 Jun;
39(7):1371-1379.
PMID: 28625505
Purpose: A fixed-dose combination (FDC) pill of amlodipine (relatively old calcium channel blocker as dihydropyridine) and olmesartan (relatively new angiotensin II receptor blocker) is used for hypertension that is not...